Related Experiment Video

Updated: May 31, 2025

Techniques for Imaging Ca2+ Signaling in Human Sperm
07:38

Techniques for Imaging Ca2+ Signaling in Human Sperm

Published on: June 16, 2010

17.1K

Systematic review of the impact of calcium channel blockers on sperm function

Emily Allard-Phillips1, Shruti Kolli2, Alice Rhoton-Vlasak1

  • 1Department of Obstetrics & Gynecology, University of Florida, Gainesville, FL 32610, USA.

Reproductive Toxicology (Elmsford, N.Y.)
|January 24, 2025
PubMed

Insights

Calcium channel blockers (CCBs) may affect male fertility by impacting sperm function. While some studies show CCBs reduce sperm motility, others find no effect on IVF fertilization, suggesting potential reversibility.

Area of Science:

  • Reproductive Biology
  • Pharmacology
  • Urology

Background:

  • Male infertility affects 30-50% of couples, often linked to sperm motility and capacitation issues.
  • Calcium ions and channels (CatSper, VDCCs) are crucial for sperm function.
  • Calcium channel blockers (CCBs) are widely used for cardiovascular conditions and may interfere with these channels.

Purpose of the Study:

  • To investigate the impact of CCBs on sperm function and male fertility.
  • To review existing literature on CCBs' effects on sperm motility, capacitation, and fertilization.
  • To assess the clinical significance for patients undergoing CCB therapy.

Main Methods:

  • Comprehensive literature review of studies on CCBs and male fertility.
  • Analysis of in vitro and animal studies examining CCB effects on sperm parameters.
  • Evaluation of impacts on sperm motility, acrosome reaction, and fertilization rates.

Main Results:

  • Varied findings: some CCBs (e.g., nifedipine) reduce sperm motility and acrosome reaction.
  • Some studies report no significant impact on in vitro fertilization (IVF) rates.
  • Animal studies show CCBs can impair spermatogenesis and sperm function without altering hormone levels.

Conclusions:

  • CCBs may reversibly impact male fertility by affecting sperm function.
  • Further in vivo studies are needed to clarify the clinical significance of CCBs for male fertility.
  • Understanding these effects is crucial for managing male patients on CCB therapy.
Keywords:
Acrosome reactionCalcium channel blockersFertilizationSperm functionSpermatogenesis

More Related Videos

Measuring Intracellular Ca2+ Changes in Human Sperm using Four Techniques: Conventional Fluorometry, Stopped Flow Fluorometry, Flow Cytometry and Single Cell Imaging19:26

Measuring Intracellular Ca2+ Changes in Human Sperm using Four Techniques: Conventional Fluorometry, Stopped Flow Fluorometry, Flow Cytometry and Single Cell Imaging

Published on: May 24, 2013

20.2K
Recording Electrical Currents across the Plasma Membrane of Mammalian Sperm Cells09:47

Recording Electrical Currents across the Plasma Membrane of Mammalian Sperm Cells

Published on: February 14, 2021

2.6K

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
449
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
449
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
767
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.1K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
299
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K